سعر دوبامينكت 0.5 مجم 20 قرص 2022

Egyptian rasagiline 0.5 mg tablets (20), Marcyrl, for idiopathic Parkinson's disease.

• Treatment of the signs and symptoms of idiopathic Parkinson's disease as initial monotherapy and as adjunct therapy to levodopa.Population: Adults with Parkinson's diseaseDailyMed / FDA

• Concomitant use with meperidine, tramadol, methadone, propoxyphene, dextromethorphan, St. John's wort, cyclobenzaprine, or other MAO inhibitors (including other selective MAO-B inhibitors). Pheochromocytoma.International label, same formulation · DailyMed / FDA

• Risk of serotonin syndrome with certain antidepressants/opioids; hypertension; falling asleep during activities; orthostatic hypotension; hallucinations/impulse-control disorders; withdrawal-emergent hyperpyrexia with abrupt cessation of dopaminergic therapy; melanoma monitoring.International label, same formulation · DailyMed / FDA

• Nonselective MAO inhibitors / meperidine / tramadol / SSRIs-SNRIs (serotonin risk)MajorContraindicated or use extreme caution due to hypertensive crisis / serotonin syndrome risk (see US label).DailyMed / FDA

• No adequate data in pregnant women; animal data suggest potential developmental toxicity at high doses — use only if benefit justifies potential risk (US label).International label, same formulation · DailyMed / FDA

• Rasagiline: Selective irreversible inhibition of MAO-B increases striatal dopamine.